Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000463341 | SCV000558561 | likely benign | Familial cancer of breast; Fanconi anemia complementation group J | 2024-01-10 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000480669 | SCV000566744 | likely benign | not specified | 2017-09-05 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Color Diagnostics, |
RCV000582312 | SCV000689397 | likely benign | Hereditary cancer-predisposing syndrome | 2017-09-22 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000990033 | SCV001140797 | likely benign | Familial cancer of breast | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000480669 | SCV004037906 | uncertain significance | not specified | 2023-08-04 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV003478008 | SCV004220725 | likely benign | not provided | 2022-05-16 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004535460 | SCV004745906 | likely benign | BRIP1-related disorder | 2019-05-16 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |